Consulting Magazine Recognizes SciVida Principal as Influential Leader

RALEIGH, NC, April 21, 2026 – SciVida is pleased to announce one of its shining stars has just been named a 2026 Top Consultant by Consulting Magazine. Brandt Nichols, PhD, Principal in the firm’s Research Triangle Park headquarters, has been recognized as an influential consulting leader in the category of “Strategy and Transformation” for his efforts in building and scaling SciVida’s oncology-focused and medical affairs strategy capabilities and best practices, elevating how we develop solutions for our clients.

Leveraging his doctorate in cancer biology, Brandt helps translate scientific and organizational complexity into winning strategies and structured, actionable plans that clients can implement with confidence. Earning perfect or near-perfect client satisfaction scores for projects he has managed, his leadership has not only expanded client relationships, increased recurring strategic work, and built scalable frameworks embedded in the firm’s practice, but also helped clients commercialize and launch life-saving therapies that directly impact patients.

“In oncology and medical affairs strategy, the work carries additional weight,” said Brandt. “Effective planning and execution can influence how quickly therapies reach patients in need of new options. While revenue and key performance indicators matter, what motivates me most is seeing a team move from uncertainty to executing with momentum.”

He continued, “I enjoy building trusted relationships where clients view me not just as an external advisor but as a thought partner invested in their long-term success. Delivering that level of impact, both organizationally and ultimately for patients, is what makes a career in life sciences consulting deeply rewarding.”

Brandt’s recognition as a 2026 Top Consultant underscores SciVida’s commitment to delivering strategic excellence at the intersection of science, transformation, and impact. His leadership exemplifies how deep scientific expertise, thoughtful strategy, and strong client partnerships can help advance innovation—ultimately accelerating the delivery of life‑changing therapies to patients who need them most.